Trials / Terminated
TerminatedNCT01190306
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- Topcon Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL), when used to treat keratoconus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The VEGA UV-A Illumination System | This is a portable electronic device designed to deliver a dose of UV-A light to the treatment area |
| DRUG | Riboflavin | Riboflavin is a solution that will be delivered to the treatment area |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2010-08-27
- Last updated
- 2022-07-12
- Results posted
- 2013-03-04
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01190306. Inclusion in this directory is not an endorsement.